High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8968105.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fifty-four grade 1 tubular breast cancers and nine non-comedo ductal carcinoma in situ samples have been analyzed for loss of heterozygosity using a series of microsatellite markers. Markers mapping to regions of the genome for which loss of heterozygosity has been documented previously in higher-grade breast cancers were selected for this analysis. Even within this group of good prognostic early breast cancers, genetic events are very common. The highest levels of loss were observed for D3S1300, which maps within an intron of the recently identified FHIT gene. High levels of loss were also observed within the ATM gene. These findings indicate that allele loss at FHIT and ATM may be an important early event in the development of sporadic breast cancer.
Medical subject headings
- Acid Anhydride Hydrolases
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma in Situ
- Carcinoma, Ductal, Breast
- Gene Deletion
- Neoplasm Proteins
- Protein Serine-Threonine Kinases
- Proteins